Distinguished in Bronchiectasis

Mariko S. Koh

Singapore, SG 
Distinguished in Bronchiectasis
Singapore, SG 
OverviewLocationsClinical Research

Overview

Mariko Koh practices in Singapore, Singapore. Ms. Koh is rated as a Distinguished expert by MediFind in the treatment of Bronchiectasis. Her top areas of expertise are Asthma, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), and Lymphofollicular Hyperplasia.

Her clinical research consists of co-authoring 107 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 10 articles and participated in 1 clinical trial in the study of Bronchiectasis.

Gender
Female

Locations

Singapore, Singapore
Other Locations
Singapore

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Investigating the Blood Eosinophil Count as a Biomarker to Guide Systemic Corticosteroid Treatment in Hospitalized Exacerbations of Asthma: a Randomized, Controlled, Open-label, Noninferiority Trial
Investigating the Blood Eosinophil Count as a Biomarker to Guide Systemic Corticosteroid Treatment in Hospitalized Exacerbations of Asthma: a Randomized, Controlled, Open-label, Noninferiority Trial
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2024
Intervention Type: Other
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety & Tolerability, and PK of INS1007 Administered Once Daily for 24 Weeks in Subjects With Non-CF Bronchiectasis - The Willow Study
Enrollment Status: Completed
Publish Date: March 27, 2023
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

107 Total Publications

Reply to Liu et al., Zhou et al., and Dong et al.
Reply to Liu et al., Zhou et al., and Dong et al.
Journal: American journal of respiratory and critical care medicine
Published: September 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Koh's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile